Everything around a malignant tumour and its metastases, from its so-called microenvironment to the patients themselves as individuals, influences cancerous growth, and ultimately the outcome of the disease. This is the take-away message from CRSy2022 – the three-day international scientific symposium that took place at the Champalimaud Foundation, in Lisbon, from 19 to 21 October.

Helena Gouveia, oncologist at the Breast Unit of the Champalimaud Foundation (CF) tells us about two important examples of collaborative endeavours between this Unit and CF’s research labs. Scientists and clinicians join efforts to do translational research/medicine – that is, to take recent scientific advances “to the patients’ bedside” as safely, quickly and efficiently as possible.

In this short video, Marcio Debiasi, oncologist at the Breast Unit of the Champalimaud Foundation, presents a study dubbed KeyPARTNER, which is being carried out in this Unit with support from industrial funders. The study’s aim is to optimize the use of chemotherapy together with immunotherapy for the treatment of so-called “triple negative” breast cancers, which are considered to be the most aggressive breast tumours.

Zoom-In on Champalimaud: Ana Beatriz Machado

Leonor Matos, Medical Oncologist at the Champalimaud Foundation’s Breast Unit, presents here the NEOPROGRAM, a project that will soon be launched in the unit, which was designed for patients who are going to receive chemotherapy or hormone therapy with curative intent. Its goal is to evaluate the benefits of different types of physical exercise for the patients’ quality of life and for tumour responses to the treatments.

This public event, organised by the RAISE (Researchers in Action for Inclusion in Science and Education) consortium composed of the NGO Native Scientist, the Champalimaud Foundation and the Instituto de Medicina Molecular João Lobo Antunes (iMM), joined the 49 ERNs that took place in 25 European countries on the same date.

On September 15th 2022, the António Champalimaud Vision Award was attributed to two physician-scientists, both of them ophthalmologists, for their pioneering work in the understanding and treatment of corneal disease. Gerrit Melles from the Netherlands Institute for Innovative Ocular Surgery, and Claes Dohlman, from Mass Eye & Ear and Harvard University, shared the prestigious one million euro award – the former for his innovative surgical methods of corneal transplant, the latter for his advancement of cornea research and the development of an artificial cornea, the “Boston K-Pro”.

Organised by Broadreach Global with the European Brain Foundation (EBC), this summit will  bring together - in a collaborative, roundtable format - a highly diverse group of key opinion leaders, from  innovators, to decision-makers. 

When it comes to sexual competition, males have the star role. Clashing bodies, locking horns, biting and kicking are all considered fair play. Since these behaviours are so salient and robust, most studies focus on male behaviour, leaving females aside. 
 

Two editions of the European Researchers’ Night will be held at the incredible premises of the Champalimaud Centre for the Unknown located in Lisbon.

To reach members of the public from underserved and underprivileged communities, the European Researchers’ Night will be supported by several pre-events and co-created by researchers and members of the public, namely students from the school programmes and artists.